These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

251 related items for PubMed ID: 20209122

  • 21. Early and late-onset preeclampsia: effects of DDAH2 polymorphisms on ADMA levels and association with DDAH2 haplotypes.
    Mendes FS, Luizon MR, Lopes ACDS, Pereira DA, Evangelista FCG, Godoi LC, Dusse LM, Alpoim PN.
    Rev Bras Ginecol Obstet; 2024; 46():. PubMed ID: 38765527
    [Abstract] [Full Text] [Related]

  • 22. The role of adipose tissue asymmetric dimethylarginine/dimethylarginine dimethylaminohydrolase pathway in adipose tissue phenotype and metabolic abnormalities in subtotally nephrectomized rats.
    Minakuchi H, Wakino S, Hosoya K, Sueyasu K, Hasegawa K, Shinozuka K, Yoshifuji A, Futatsugi K, Komatsu M, Kanda T, Tokuyama H, Hayashi K, Itoh H.
    Nephrol Dial Transplant; 2016 Mar; 31(3):413-23. PubMed ID: 26516203
    [Abstract] [Full Text] [Related]

  • 23. Regulation of the ADMA-DDAH system in endothelial cells: a novel mechanism for the sterol response element binding proteins, SREBP1c and -2.
    Ivashchenko CY, Bradley BT, Ao Z, Leiper J, Vallance P, Johns DG.
    Am J Physiol Heart Circ Physiol; 2010 Jan; 298(1):H251-8. PubMed ID: 19915177
    [Abstract] [Full Text] [Related]

  • 24. Dimethylarginine Dimethylaminohydrolase 1 Polymorphisms and Venous Intimal Hyperplasia in Hemodialysis Patients.
    Wu CC, Hsieh MY, Lee CK, Chuang SY, Chung MY, Lin CC.
    Am J Nephrol; 2019 Jan; 50(6):454-464. PubMed ID: 31639806
    [Abstract] [Full Text] [Related]

  • 25. Upregulation of DDAH2 Limits Pulmonary Hypertension and Right Ventricular Hypertrophy During Chronic Hypoxia in Ddah1 Knockout Mice.
    Hannemann J, Glatzel A, Hillig J, Zummack J, Schumacher U, Lüneburg N, Harbaum L, Böger R.
    Front Physiol; 2020 Jan; 11():597559. PubMed ID: 33281630
    [Abstract] [Full Text] [Related]

  • 26. ADMA reduction does not protect mice with streptozotocin-induced diabetes mellitus from development of diabetic nephropathy.
    Rodionov RN, Heinrich A, Brilloff S, Jarzebska N, Martens-Lobenhoffer J, Bode-Böger SM, Todorov VT, Hugo CPM, Weiss N, Hohenstein B.
    Atheroscler Suppl; 2017 Nov; 30():319-325. PubMed ID: 29096857
    [Abstract] [Full Text] [Related]

  • 27. Inhibition of DDAH1, but not DDAH2, results in apoptosis of a human trophoblast cell line in response to TRAIL.
    Lumicisi BA, Cartwright JE, Leslie K, Wallace AE, Whitley GS.
    Hum Reprod; 2015 Aug; 30(8):1813-9. PubMed ID: 26082478
    [Abstract] [Full Text] [Related]

  • 28. Septic shock is correlated with asymmetrical dimethyl arginine levels, which may be influenced by a polymorphism in the dimethylarginine dimethylaminohydrolase II gene: a prospective observational study.
    O'Dwyer MJ, Dempsey F, Crowley V, Kelleher DP, McManus R, Ryan T.
    Crit Care; 2006 Aug; 10(5):R139. PubMed ID: 17002794
    [Abstract] [Full Text] [Related]

  • 29. Dimethylarginine Dimethylaminohydrolase 1 Deficiency Induces the Epithelial to Mesenchymal Transition in Renal Proximal Tubular Epithelial Cells and Exacerbates Kidney Damage in Aged and Diabetic Mice.
    Shi L, Zhao C, Wang H, Lei T, Liu S, Cao J, Lu Z.
    Antioxid Redox Signal; 2017 Dec 01; 27(16):1347-1360. PubMed ID: 28594240
    [Abstract] [Full Text] [Related]

  • 30. Tissue-specific downregulation of dimethylarginine dimethylaminohydrolase in hyperhomocysteinemia.
    Dayal S, Rodionov RN, Arning E, Bottiglieri T, Kimoto M, Murry DJ, Cooke JP, Faraci FM, Lentz SR.
    Am J Physiol Heart Circ Physiol; 2008 Aug 01; 295(2):H816-25. PubMed ID: 18567702
    [Abstract] [Full Text] [Related]

  • 31. Overexpression of dimethylarginine dimethylaminohydrolase 1 attenuates airway inflammation in a mouse model of asthma.
    Kinker KG, Gibson AM, Bass SA, Day BP, Deng J, Medvedovic M, Figueroa JA, Hershey GK, Chen W.
    PLoS One; 2014 Aug 01; 9(1):e85148. PubMed ID: 24465497
    [Abstract] [Full Text] [Related]

  • 32. Relationship between asymmetric dimethylarginine, nitrite and genetic polymorphisms: Impact on erectile dysfunction therapy.
    Azevedo AMM, Brites-Anselmi G, Pinheiro LC, de Almeida Belo V, Coeli-Lacchini FB, Molina CAF, de Andrade MF, Tucci S, Hirsch E, Tanus-Santos JE, Lacchini R.
    Nitric Oxide; 2017 Dec 01; 71():44-51. PubMed ID: 29074293
    [Abstract] [Full Text] [Related]

  • 33. Dimethylarginine dimethylaminohydrolase 1 regulates nerve growth factor-promoted differentiation of PC12 cells in a nitric oxide-dependent but asymmetric dimethylargenine-independent manner.
    Wang S, Hu CP, Yuan Q, Zhang WF, Zhou Z, Nie SD, Jiang JL, Li YJ.
    J Neurosci Res; 2012 Jun 01; 90(6):1209-17. PubMed ID: 22488726
    [Abstract] [Full Text] [Related]

  • 34. Dimethylarginine dimethylaminohydrolase-1 (DDAH1) is frequently upregulated in prostate cancer, and its overexpression conveys tumor growth and angiogenesis by metabolizing asymmetric dimethylarginine (ADMA).
    Reddy KRK, Dasari C, Duscharla D, Supriya B, Ram NS, Surekha MV, Kumar JM, Ummanni R.
    Angiogenesis; 2018 Feb 01; 21(1):79-94. PubMed ID: 29150732
    [Abstract] [Full Text] [Related]

  • 35. Dysfunction of endothelial NO system originated from homocysteine-induced aberrant methylation pattern in promoter region of DDAH2 gene.
    Zhang JG, Liu JX, Li ZH, Wang LZ, Jiang YD, Wang SR.
    Chin Med J (Engl); 2007 Dec 05; 120(23):2132-7. PubMed ID: 18167189
    [Abstract] [Full Text] [Related]

  • 36. Correlations of DDAH1 transcript variants with human endothelial asymmetric dimethylarginine metabolizing activity.
    Sun T, Zhou JP, Kuang DB, Li MP, Xiong Y, Tang J, Xia J, Bai YP, Yang GP, Li YJ, Chen XP.
    Am J Hypertens; 2013 Dec 05; 26(12):1437-44. PubMed ID: 23864585
    [Abstract] [Full Text] [Related]

  • 37. Human dimethylarginine dimethylaminohydrolase 1 inhibition by proton pump inhibitors and the cardiovascular risk marker asymmetric dimethylarginine: in vitro and in vivo significance.
    Tommasi S, Elliot DJ, Hulin JA, Lewis BC, McEvoy M, Mangoni AA.
    Sci Rep; 2017 Jun 06; 7(1):2871. PubMed ID: 28588208
    [Abstract] [Full Text] [Related]

  • 38. Genetic and environmental determinants of dimethylarginines and association with cardiovascular disease in patients with type 2 diabetes.
    Anderssohn M, McLachlan S, Lüneburg N, Robertson C, Schwedhelm E, Williamson RM, Strachan MW, Ajjan R, Grant PJ, Böger RH, Price JF.
    Diabetes Care; 2014 Jun 06; 37(3):846-54. PubMed ID: 24186881
    [Abstract] [Full Text] [Related]

  • 39. DDAH2 alleviates myocardial fibrosis in diabetic cardiomyopathy through activation of the DDAH/ADMA/NOS/NO pathway in rats.
    Zhu ZD, Ye JM, Fu XM, Wang XC, Ye JY, Wu XR, Hua P, Liao YQ, Xuan W, Duan JL, Li WY, Fu H, Xia ZH, Zhang X.
    Int J Mol Med; 2019 Feb 06; 43(2):749-760. PubMed ID: 30569164
    [Abstract] [Full Text] [Related]

  • 40. Redefining the biological and pathophysiological role of dimethylarginine dimethylaminohydrolase 2.
    Nair PC, Mangoni AA, Rodionov RN.
    Trends Mol Med; 2024 Jun 06; 30(6):552-561. PubMed ID: 38553332
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 13.